Peraso Reports Steep Q1 Revenue Decline and Widening Losses, Cash Dwindles Amid Operational Challenges
PRSO sits 22% above its 52-week low of $0.771 on elevated volume (4.8× avg).
Summary
Peraso Inc. reported significantly lower Q1 2026 revenue and wider net losses, confirming severe financial deterioration and continued cash burn, despite meeting its previously lowered guidance.
Key Events · Earnings and Guidance · PRSO
-
Significant Revenue Decline
Total net revenue for Q1 2026 was $1.0 million, a substantial decrease from $3.9 million in Q1 2025 and $2.9 million in the prior quarter.
-
Widening Net Loss
GAAP net loss increased to $2.5 million ($0.22 per share) in Q1 2026, compared to a $0.5 million loss ($0.08 per share) in Q1 2025.
-
Deteriorating Profitability
Adjusted EBITDA worsened to negative $2.3 million in Q1 2026, from negative $0.3 million in Q1 2025.
-
Cash Position Declines
Cash and cash equivalents decreased to $2.672 million as of March 31, 2026, from $2.886 million at the end of 2025.
Analysis · PRSO · Manufacturing
This filing confirms severe financial deterioration for Peraso Inc., with a significant year-over-year revenue drop and widening losses. While the company met its previously lowered Q1 guidance, the underlying trends of declining sales and increasing cash burn are highly concerning, especially given the prior "going concern" disclosure. The low cash balance and ongoing operational challenges suggest continued financial pressure and a need for further capital.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.9% of the 1612 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRSO was trading at $0.94 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $17.4M. The 52-week trading range was $0.77 to $2.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.